Improving Vocal Volume and Quality of Life for People with Parkinson’s Disease (PD) utilizing EMST and SPEAK OUT!® in the In-Patient Multimodal Intensive Neurorehabilitation And Care Setting.
Objective: To demonstrate the ability to improve vocal volume and improve perceived disability and quality of life in PD patients at the unstructured conversational level during…Clinician Advisory Community: Guiding The Michael J. Fox Foundation’s Mission Through Front-Line Intelligence
Objective: Create a survey-ready community of U.S.-based clinicians to share care-focused inputs that inform The Michael J. Fox Foundation’s (MJFF) research funding and recruitment, policy,…Long-Term Benefits of Weekly Group Physiotherapy in Slowing Parkinson’s Progression:A 12-Month Non-Randomized Controlled Trial
Objective: To investigate the effects of weekly group PT programs to reduce the progression of motor symptoms severity in PwPD Background: The short-term benefits of…G-Can, the GBA1 Canada Initiative
Objective: G-Can, the GBA1 Canada Initiative, is an open-science platform which aims to advance GBA1 research and develop treatments for GBA1 mutation-related Parkinson's disease (PD).…The Benefits of Whole-Body Electro Muscle Stimulation (WB-EMS) in a patient with Parkinson’s Disease
Objective: To determine the motor and non-motor benefits of WB-EMS in a patient with Parkinson’s disease Background: Parkinson’s disease causes both motor and non-motor symptoms.…A Comparison of Coordinated Reset and Low-Frequency Vibrotactile Stimulation for the Treatment of Parkinson’s Symptoms
Objective: This research examines a novel non-invasive vibrotactile device which stimulates fingertips in a pattern aiming to disrupt pathological physiological beta-band oscillations believed to be…Enrollment Challenges and Strategies in Early-Stage Parkinson’s Disease Clinical Trials: Comparing Treatment-Naïve and Previously Treated Patient Populations
Objective: To evaluate enrollment rates and challenges in clinical trials of disease-modifying therapies (DMTs) for early-stage Parkinson's disease (PD), comparing treatment-naïve patients with those permitted prior symptomatic…Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Motor Complications in Parkinson’s Disease
Objective: To evaluate the impact of intravenous (IV) allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) treatment on motor complications in Parkinson’s disease (PD). Background: Motor…Long-term effects of a periodic intensive rehabilitation program in People with Parkinson’s Disease
Objective: This study aimed to examine the long-term effects of a periodic intensive rehabilitation program incorporating tele-tools on the progression of motor symptoms in people…NIH funds Gut-Brain Parkinson’s Disease Consortium
Objective: Describe the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) multicenter (UO1) Consortium on PD Gut-Brain Communication. Background: A 2024 Notice of Funding…
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 436
- Next Page »